SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 25th, 2012 • Puramed Bioscience Inc. • Pharmaceutical preparations • Utah
THIS SECURITIES PURCHASE AGREEMENT, dated as of September 7, 2012 (this “Agreement”), is entered into by and between PURAMED BIOSCIENCE, INC., a Minnesota corporation (the “Company”), and TONAQUINT, INC., a Utah corporation, its successors or assigns (the “Buyer”).
ContractWarrant Agreement • September 25th, 2012 • Puramed Bioscience Inc. • Pharmaceutical preparations • Utah
THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO PURAMED BIOSCIENCE, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
PuraMed BioScience, Inc. Convertible Promissory NoteConvertible Promissory Note • September 25th, 2012 • Puramed Bioscience Inc. • Pharmaceutical preparations • Utah
This Convertible Promissory Note (“Note”) is issued pursuant to that certain Securities Purchase Agreement dated September 7, 2012, as the same may be amended from time to time (the “Agreement”), by and between TONAQUINT, INC., a Utah corporation, or its registered assigns (the “Holder”), and PURAMED BIOSCIENCE, INC., a Minnesota corporation (the “Company”).
